Stock Events

Stock Events

Anika Therapeutics 

€12.6
0
+€0.1+0.8% Today

Statistics

Day High
12.6
Day Low
12.1
52W High
13.1
52W Low
6.9
Volume
0
Avg. Volume
6
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q4 2025
Next
-0.11
0.02
0.14
0.26
Expected EPS
-0.059957800000000006
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AKP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap18.22B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare market, offering products for joint reconstruction similar to Anika's orthobiologics.
Stryker
SYK
Mkt Cap129.89B
Stryker Corporation is a direct competitor in the orthopedic sector, providing a range of products for joint replacement and orthobiologic solutions.
Medtronic
MDT
Mkt Cap111.97B
Medtronic plc offers products in the orthopedic and tissue regeneration areas, competing with Anika's solutions for bone healing and regeneration.
Johnson & Johnson
JNJ
Mkt Cap574.66B
Johnson & Johnson, through its DePuy Synthes division, competes in the orthopedics market, particularly in joint reconstruction, a key area for Anika.
Boston Scientific
BSX
Mkt Cap91.83B
Boston Scientific Corporation competes with Anika in the medical devices sector, particularly in products related to pain management and chronic conditions.
Integra Lifesciences
IART
Mkt Cap725.6M
Integra LifeSciences Holdings Corporation offers products for orthopedic and tissue technologies, competing in the same space as Anika.
Baxter International
BAX
Mkt Cap8.85B
Baxter International Inc. competes in the broader healthcare and medical devices sector, including products for regenerative medicine and orthopedics.
Align Technology
ALGN
Mkt Cap12.4B
Align Technology, Inc. competes indirectly by offering orthodontic products, which can intersect with Anika's offerings in the broader orthopedic and healthcare market.

About

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Show more...
CEO
Dr. Cheryl Renee Blanchard Ph.D.
Employees
288
Country
United States
ISIN
US0352551081

Listings

STU
DE
AKP.STU
XNAS
US
ANIK
BOATS
BOATS
ANIK.BOATS
F
DE
AKP.F

0 Comments

Share your thoughts

FAQ

What is Anika Therapeutics stock price today?▼
The current price of AKP.STU is €12.6 EUR — it has increased by +0.8% in the past 24 hours. Watch Anika Therapeutics stock price performance more closely on the chart.
What is Anika Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Anika Therapeutics stocks are traded under the ticker AKP.STU.
Is Anika Therapeutics stock price growing?▼
AKP.STU stock has fallen by -4.69% compared to the previous week, the month change is a -1.61% fall, over the last year Anika Therapeutics has showed a +3.39% increase.
When is the next Anika Therapeutics earnings date?▼
Anika Therapeutics is going to release the next earnings report on May 07, 2026.
What were Anika Therapeutics earnings last quarter?▼
AKP.STU earnings for the last quarter are 0.26 EUR per share, whereas the estimation was -0.11 EUR resulting in a +348% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Anika Therapeutics have?▼
As of April 13, 2026, the company has 288 employees.
In which sector is Anika Therapeutics located?▼
Anika Therapeutics operates in the Health & Wellness sector.
When did Anika Therapeutics complete a stock split?▼
Anika Therapeutics has not had any recent stock splits.
Where is Anika Therapeutics headquartered?▼
Anika Therapeutics is headquartered in Bedford, United States.